Jin Medical International Stock Fundamentals
| ZJYL Stock | 0.64 0.02 3.03% |
Fundamental analysis of JIN MEDICAL allows traders to better anticipate movements in JIN MEDICAL's stock price by examining its financial health and performance throughout various phases of its business cycle.
At this time, JIN MEDICAL's Selling And Marketing Expenses is quite stable compared to the past year. Total Other Income Expense Net is expected to rise to about 658 K this year, although the value of Selling General Administrative will most likely fall to about 2.2 M. JIN | Select Account or Indicator | Build AI portfolio with JIN Stock |
JIN MEDICAL INTERNATIONAL Company Shares Outstanding Analysis
JIN MEDICAL's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current JIN MEDICAL Shares Outstanding | 156.55 M |
Most of JIN MEDICAL's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JIN MEDICAL INTERNATIONAL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
JIN Shares Outstanding Historical Pattern
Today, most investors in JIN MEDICAL Stock are looking for potential investment opportunities by analyzing not only static indicators but also various JIN MEDICAL's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of JIN MEDICAL shares outstanding as a starting point in their analysis.
JIN MEDICAL Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
JIN Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, JIN MEDICAL INTERNATIONAL has 156.55 M of shares currently outstending. This is 13.29% lower than that of the Health Care Equipment & Supplies sector and 10.52% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 72.62% higher than that of the company.
JIN MEDICAL INTERNATIONAL Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining JIN MEDICAL's current stock value. Our valuation model uses many indicators to compare JIN MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across JIN MEDICAL competition to find correlations between indicators driving JIN MEDICAL's intrinsic value. More Info.JIN MEDICAL INTERNATIONAL is rated fifth in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for JIN MEDICAL INTERNATIONAL is roughly 2.25 . At this time, JIN MEDICAL's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value JIN MEDICAL by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.JIN Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JIN MEDICAL's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics of similar companies.JIN MEDICAL is currently under evaluation in shares outstanding category among its peers.
JIN Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0578 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 85.15 M | ||||
| Shares Outstanding | 156.55 M | ||||
| Shares Owned By Insiders | 75.84 % | ||||
| Shares Owned By Institutions | 0.64 % | ||||
| Number Of Shares Shorted | 752.53 K | ||||
| Price To Book | 3.48 X | ||||
| Price To Sales | 4.27 X | ||||
| Revenue | 23.5 M | ||||
| Gross Profit | 9.61 M | ||||
| EBITDA | 3.98 M | ||||
| Net Income | 3.42 M | ||||
| Total Debt | 11.6 M | ||||
| Book Value Per Share | 0.18 X | ||||
| Cash Flow From Operations | (1.21 M) | ||||
| Short Ratio | 3.88 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Number Of Employees | 269 | ||||
| Beta | 9.91 | ||||
| Market Capitalization | 100.3 M | ||||
| Total Asset | 45.8 M | ||||
| Retained Earnings | 20.02 M | ||||
| Working Capital | 25.66 M | ||||
| Net Asset | 45.8 M |
About JIN MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JIN MEDICAL INTERNATIONAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 717.4 K | 849 K | |
| Total Revenue | 27 M | 22.1 M | |
| Cost Of Revenue | 16.1 M | 14.3 M | |
| Sales General And Administrative To Revenue | 0.12 | 0.08 | |
| Research And Ddevelopement To Revenue | 0.06 | 0.06 | |
| Capex To Revenue | 0.04 | 0.05 | |
| Revenue Per Share | 0.17 | 0.16 | |
| Ebit Per Revenue | 0.15 | 0.18 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out JIN MEDICAL Piotroski F Score and JIN MEDICAL Altman Z Score analysis. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.676 | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.353 | Return On Assets |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.